Healthcare & Life Sciences
Akamara Therapeutics
About
Akamara Therapeutics develops supramolecular structures aimed at B-cell immunotherapy, with a lead molecule targeting triple negative breast cancer.
Explore Akamara Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.